Autor: "Morten BC" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Autorzy:: Steffens Reinhardt L; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW 2305, Australia.; Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
Groen K; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW 2305, Australia.; Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
Morten BC; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW 2305, Australia.; Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
Bourdon JC; School of Medicine, Ninewells Hospital and Medical School, The University of Dundee, Dundee DD1 9SY, UK.
Avery-Kiejda KA; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW 2305, Australia.; Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Jun 15; Vol. 23 (12). Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Tumor Suppressor Protein p53*/metabolism
Disease-Free Survival ; Female ; Humans ; Mutation ; Progression-Free Survival ; Protein Isoforms/genetics ; Protein Isoforms/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk.
Autorzy:: Eiholzer RA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Mehta S; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
Kazantseva M; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
Drummond CJ; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
McKinney C; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Young K; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Slater D; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.; Hunter Medical Research Institute, New South Wales 2305, Australia.
Morten BC; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.; Hunter Medical Research Institute, New South Wales 2305, Australia.
Avery-Kiejda KA; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.; Hunter Medical Research Institute, New South Wales 2305, Australia.
Lasham A; Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1023, New Zealand.
Fleming N; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Morrin HR; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.
Reader K; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Royds JA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Landmann M; Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Petrich S; Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Reddel R; Children's Medical Research Institute, University of Sydney, Westmead, New South Wales 2145, Australia.
Huschtscha L; Children's Medical Research Institute, University of Sydney, Westmead, New South Wales 2145, Australia.
Taha A; Department of Neurosurgery, Southern District Heath Board, Dunedin 9016, New Zealand.
Hung NA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Slatter TL; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
Braithwaite AW; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.; Malaghan Institute of Medical Research, Wellington 6242, New Zealand.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2020 Sep 01; Vol. 12 (9). Date of Electronic Publication: 2020 Sep 01.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues- A Preliminary Study.
Autorzy:: Morten BC; Medical Genetics, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.; Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, 2308, Australia.
Scott RJ; Medical Genetics, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.; Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, 2308, Australia.; Pathology North, John Hunter Hospital, New Lambton Heights, NSW, 2305, Australia.
Avery-Kiejda KA; Medical Genetics, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.; Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, 2308, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Nov 10; Vol. 11 (11), pp. e0165930. Date of Electronic Publication: 2016 Nov 10 (Print Publication: 2016).
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Breast/*pathology
Breast Neoplasms/*genetics
RNA, Messenger/*genetics
Reverse Transcriptase Polymerase Chain Reaction/*methods
Tumor Suppressor Protein p53/*genetics
Breast/metabolism ; Breast Neoplasms/pathology ; Cohort Studies ; Female ; Gene Expression Profiling/methods ; Humans ; Paraffin Embedding/methods ; Pilot Projects ; Protein Isoforms/genetics ; Tissue Fixation/methods

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Morten BC"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język